ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function

ALS相关的KIF5A突变会消除自身抑制,导致毒性功能获得。

阅读:4
作者:Desiree M Baron ,Adam R Fenton ,Sara Saez-Atienzar ,Anthony Giampetruzzi ,Aparna Sreeram ,Shankaracharya ,Pamela J Keagle ,Victoria R Doocy ,Nathan J Smith ,Eric W Danielson ,Megan Andresano ,Mary C McCormack ,Jaqueline Garcia ,Valérie Bercier ,Ludo Van Den Bosch ,Jonathan R Brent ,Claudia Fallini ,Bryan J Traynor ,Erika L F Holzbaur ,John E Landers

Abstract

Understanding the pathogenic mechanisms of disease mutations is critical to advancing treatments. ALS-associated mutations in the gene encoding the microtubule motor KIF5A result in skipping of exon 27 (KIF5AΔExon27) and the encoding of a protein with a novel 39 amino acid residue C-terminal sequence. Here, we report that expression of ALS-linked mutant KIF5A results in dysregulated motor activity, cellular mislocalization, altered axonal transport, and decreased neuronal survival. Single-molecule analysis revealed that the altered C terminus of mutant KIF5A results in a constitutively active state. Furthermore, mutant KIF5A possesses altered protein and RNA interactions and its expression results in altered gene expression/splicing. Taken together, our data support the hypothesis that causative ALS mutations result in a toxic gain of function in the intracellular motor KIF5A that disrupts intracellular trafficking and neuronal homeostasis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。